Neurological manifestations with jugular vein thrombosis linked to an inflammatory profile may be a sequela of long COVID
Abstract More than 670 million cases of coronavirus disease 2019 (COVID‐19) have been recorded worldwide in the 3 years since the start of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic. About 45% of survivors of COVID‐19 develop a syndrome known as long‐term COVID, in whi...
Saved in:
| Main Authors: | Elizabeth Mendoza‐Portillo, Estefania Aleman‐Navarro, G. Aleph Prieto, Yvonne Rosenstein, Jose J. Lozano‐Nuevo, Araceli Perez‐Lopez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-12-01
|
| Series: | Neuroprotection |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/nep3.24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deep vein thrombosis - the review
by: Karol Stępniak, et al.
Published: (2024-11-01) -
Recurrent deep vein thrombosis in children with malignant blood diseases: literature review
by: D. S. Morozova, et al.
Published: (2019-07-01) -
VENOUS THROMBOSIS AND PULMONARY EMBOLISM
by: I. N. Bokarev, et al.
Published: (2011-08-01) -
Clinical outcomes of cancer-associated isolated distal deep vein thrombosis: a comparison between asymptomatic and symptomatic thrombosis—findings from the ONCO DVT Study
by: Yoshito Ogihara, et al.
Published: (2025-02-01) -
Anticoagulants in the treatment of superficial vein thrombosis of lower limbs: possibilities and limitations
by: I. S. Yavelov, et al.
Published: (2022-01-01)